News

Displaying 1 - 20 of 25

Latest analysis highlights changing trends in illicit production of amphetamine in Europe

15.12.2011

Increased capacity and sophistication in the illicit amphetamine market are among developments reviewed in the EMCDDA–Europol analysis Amphetamine: a European Union perspective in the global context (1). Published today, the report describes how patterns and trends are changing in the production...

Registration opens for European summer school on illicit drugs

15.12.2011

The Lisbon-based Instituto Superior das Ciências do Trabalho e da Empresa (ISCTE) and the EU drugs agency (EMCDDA) are currently collaborating on a summer school programme entitled: ‘Illicit drugs in Europe: supply, demand and public policies’. Registration opens today for the course which will...

EMCDDA briefing paper highlights need for range of tools to counter threat of emerging drugs

14.12.2011

‘The speed at which new psychoactive substances can appear and be distributed now challenges the established procedure of passing legislation to control a substance in each country,’ according to a new publication released today by the EU drugs agency (EMCDDA). ‘Responding to new psychoactive...

EMCDDA launches first European quality standards to improve drug prevention in the EU

09.12.2011

‘Prevention’ is one of the first issues to be mentioned in the public debate on drugs, but evidence of what works in practice to prevent drug use is often overlooked. Today the EU drugs agency (EMCDDA) launches the first European ‘how to’ guide on conducting high-quality drug prevention. Entitled...

International experts to examine the influence of social and economic environments on substance use

05.12.2011

Leading international experts in prevention research will meet in Lisbon from 8–9 December to examine the influence of social and economic environments on substance use. Over 100 participants from some 20 countries will gather at the 2nd International Conference of the European Society for...

World AIDS Day 2011

29.11.2011

1 December: World AIDS Day The EMCDDA and ECDC have contributed to a special issue of Eurosurveillance marking World AIDS Day. This edition contains an editorial and scientific papers raising awareness on the need for scaling up HIV/AIDS prevention in Europe. » Information on the seminar (...

EU drugs agency hosts 2011 ESPAD meeting in Lisbon

28.11.2011

The EMCDDA and the European School Survey Project on Alcohol and Other Drugs (ESPAD) pledged to scale up their cooperation today in a joint statement adopted at the 2011 ESPAD project meeting. The event, hosted by the EMCDDA in Lisbon (27–29 November), brings together participants from 39 European...

Drugs report: Commissioner Malmström calls for vigilance on synthetic drugs and asks more anti-trafficking efforts

15.11.2011

The Annual report 2011, released today by the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA), shows drug use to be relatively stable in Europe, with some positive signs that cocaine use may have peaked and that cannabis use continues to decline among young people. But signs of...

Policies and responses must be fit to face the challenges of the next decade, says drugs agency chief

15.11.2011

The Annual report 2011: the state of the drugs problem in Europe is ‘one of contrasts’, says the EU drugs agency (EMCDDA). Launched today in Lisbon, the report shows drug use to be relatively stable in Europe, with some positive signs that cocaine use may have peaked and that cannabis use continues...

EU drugs agency releases new analysis of Europe’s changing opioid problem

15.11.2011

Heroin use continues to account for the largest share of drug-related diseases and deaths in the EU. The EU drugs agency (EMCDDA) estimates that there are over 1.3 million regular opioid users in the EU and Norway. And around half (51 %) of the drug users entering specialised treatment in Europe...

Update — risk of HIV outbreaks among drug injectors in the EU

14.11.2011

Over the last decade, gains have been made within the EU in addressing HIV infection among injecting drug users — these include a greater availability of prevention, treatment and harm-reduction measures. Other factors, such as the decline in injecting drug use in several countries, are also likely...

EMCDDA celebrates scientific writing with new award

11.11.2011

Five scientific papers judged to enhance understanding of the European drugs problem will be acclaimed on Monday evening in Lisbon in a new award ceremony hosted by the EU drugs agency (EMCDDA) and its Scientific Committee (1). The prize, to be awarded annually in Lisbon, celebrates scientific...

Seven ways to reduce infections among people who inject drugs

12.10.2011

Seven interventions, one aim: no infections among people who inject drugs. In a new guidance document out today, EU agencies ECDC and the EMCDDA have joined forces to identify seven interventions to reduce and prevent infectious diseases in this vulnerable population. Many European countries have...

15 November 2011, Lisbon — EU drugs agency to present the latest statistics, trends and analysis

10.10.2011

The EU drugs agency (EMCDDA) will present its annual assessment of Europe’s drugs problem in its Annual report 2011 to be released on 15 November in Lisbon. The report, the agency’s flagship publication, provides the latest data and commentary on the drug situation across the 27 EU Member States,...

Survey results: youth attitudes to drugs

11.07.2011

The European Commission released today the results of its fourth survey exploring  Youth attitudes on drugs (1). This ‘Flash Eurobarometer’ is based on telephone interviews conducted in May 2011 with over 12 000 randomly selected young people (aged 15–24) in all 27 EU Member States. It builds on...

Khat use in Europe: update and policy implications

04.07.2011

‘The number of khat users in Europe appears to be growing, yet the scale and nature of the problem is poorly understood’. This is according to a new publication on the subject released today by the EU drugs agency (EMCDDA). ‘Khat use in Europe: implications for European policy’ is published in the...

Drug use in Europe still a major threat to public health

23.06.2011

Drug use in Europe still represents a major threat to public health and is responsible for between 7 000 and 8 000 fatal overdoses every year in the EU. Europe’s drugs problem is also changing, with more problems now associated with the use of stimulant drugs, such as cocaine, and new substances...

EMCDDA Scientific Committee elects new leaders

18.05.2011

The EMCDDA Scientific Committee, meeting in Lisbon this week, elected its new Chair and Vice Chair for the next three years. Dr Marina Davoli (Italian) was elected by an overwhelming majority to the position of Chair and Prof. Dr Gerhard Bühringer (German) to the position of Vice Chair. The...

First international multidisciplinary forum on new drugs, 11–12 May 2011, Lisbon

13.05.2011

Leading European and international experts on new drugs met in Lisbon from 11–12 May at the First international multidisciplinary forum on new drugs, organised by the EU drugs agency (EMCDDA). The participating experts were invited for their technical expertise and research in the field of new...

New drugs becoming available at ‘unprecedented pace’, says report

11.05.2011

New psychoactive substances are becoming widely available at an ‘unprecedented pace’. This is according to the EMCDDA–Europol 2010 annual report on new drugs entering the European market released today in Lisbon (1). In 2010, a record number of new drugs were officially reported to the EMCDDA and...
Loading